Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT03319004
Other study ID # 3-2017-0145
Secondary ID
Status Enrolling by invitation
Phase N/A
First received October 1, 2017
Last updated October 22, 2017
Start date July 19, 2017
Est. completion date July 18, 2018

Study information

Verified date October 2017
Source Gangnam Severance Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

For verifying the phase lag entropy as the tool for measurement of level of consciousness, the investigators compared phase lag entropy to bispectral index. Using Target-Controlled Infusion pump, propofol was infused for sedation during the spinal anesthesia. The investigators measured Observer's Assessment of Alertness/Sedation Scale as the propofol concentration rises. At the same time, The investigators observed phase lag entropy score and bispectral index score.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 27
Est. completion date July 18, 2018
Est. primary completion date January 31, 2018
Accepts healthy volunteers No
Gender All
Age group 20 Years to 50 Years
Eligibility Inclusion Criteria:

- patients who require sedation during the spinal anesthesia

Exclusion Criteria:

- dementia, CVA patients, patients have problems with communication

Study Design


Related Conditions & MeSH terms

  • Surgery Requiring Spinal Anesthesia

Intervention

Device:
apply phase lag entropy sensor
apply phase lag entropy sensor as well as bispectral index sensor on forehead during the sedation using propofol

Locations

Country Name City State
Korea, Republic of Gangnam Severance Hospital Seoul

Sponsors (1)

Lead Sponsor Collaborator
Gangnam Severance Hospital

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary phase lag entropy score phase lag entropy score through study completion, an average of 1 year